Sharekhan

Virinchi Ltd

Thu 13/03/2025,15:52:25 | NSE : VIRINCHI

₹ 23.65-0.20 (-0.84%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 23.85

Previous Close

₹ 23.85

Volume

148286

Mkt Cap ( Rs. Cr)

₹242.76

High

₹ 24.41

Low

₹ 23.59

52 Week High

₹ 41.90

52 Week Low

₹ 23.00

Book Value Per Share

₹ 46.99

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Virinchi Ltd

Your Vote -

Buy

89.19%

Hold

9.46%

Sell

1.35%

89.19%

222 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

23.65

1

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Virinchi Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Virinchi L - General Updates

    7 Mar 2025, 5:30PM Virinchi Limited has informed the Exchange about General Updates
  • Virinchi L - Incorporation Of Wholly Owned Subsidiary

    7 Mar 2025, 5:27PM please find enclosed intimation regarding incorporation of wholly owned subsidiary.
  • Virinchi L - Alteration Of Capital and Fund Raising-XBRL

    6 Mar 2025, 5:31PM VIRINCHI LIMITED has informed the Exchange regarding Allotment of Securities
  • Virinchi L - Allotment of Securities

    6 Mar 2025, 5:30PM Virinchi Limited has informed the Exchange regarding allotment of 231716 securities pursuant to ESOP/ESPS at its meeting held on March 06, 2025
  • Virinchi L - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    6 Mar 2025, 5:22PM Please find enclosed intimation regarding allotment of equity shares under Virinchi Employees Stock Option Scheme, 2022
  • Virinchi L - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(

    28 Feb 2025, 11:09AM The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SE
  • Virinchi L - General Updates

    27 Feb 2025, 10:52AM Virinchi Limited has informed the Exchange about General Updates
  • Virinchi L - M/S. Virinchi Healthcare Private Limited(Wholly-Owned Subsidiary Of Virinchi Limited) Appoints Dr. Krishna Reddy

    27 Feb 2025, 10:49AM Please find enclosed announcement regarding appointment of Dr. Krishna Reddy Nallamalla, one of Co-Founder of CARE group of hospitals and renowned Car
  • Virinchi L - Integrated Filing- Financial

    5 Feb 2025, 5:24PM Integrated filing
  • Virinchi L - Integrated Filing (Financial)

    5 Feb 2025, 5:20PM Integrated financials filing for the quarter and nine months ended December 31, 2024.
  • Virinchi L - Updates

    31 Jan 2025, 12:00PM Virinchi Limited has informed the Exchange regarding ''.
  • Virinchi L - Copy of Newspaper Publication

    29 Jan 2025, 11:46AM Virinchi Limited has informed the Exchange about Copy of Newspaper Publication
  • Virinchi L Q3 net profit up 32.80% at Rs 3.32 cr

    28 Jan 2025, 10:10AM The company reported standalone net profit of Rs 3.32 crore for the quarter ended December 31, 2024 as compared to Rs 2.50 crore in the same period la
  • Virinchi L - Outcome of Board Meeting

    27 Jan 2025, 9:11PM Virinchi Limited has informed the Exchange regarding Board meeting held on January 27, 2025.
  • Virinchi L - Financial Result Updates

    27 Jan 2025, 9:10PM Virinchi Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Virinchi L - Board Meeting Outcome for Outcome Of The Board Meeting

    27 Jan 2025, 9:09PM please find enclosed outcome of the Board Meeting
  • Virinchi L - The Un-Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended

    27 Jan 2025, 9:06PM Please find enclosed Un-Audited and Consolidated Financial Results for the Quarter and Nine-months ended December 31, 2024
  • Virinchi L - Board Meeting Intimation

    20 Jan 2025, 6:11PM VIRINCHI LIMITED has informed the Exchange about Board Meeting to be held on 27-Jan-2025 to consider and approve the Quarterly Unaudited Financial res
  • Virinchi L - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Monday, Ja

    20 Jan 2025, 6:07PM Virinchi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 ,inter alia, to consider and approve
  • Virinchi L has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    18 Jan 2025, 5:30PM As of December 2024, 37.60% is owned by Promoters and 62.40% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 36.08% and F
  • Virinchi L - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    15 Jan 2025, 12:09PM Virinchi Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Virinchi L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Jan 2025, 12:06PM Please find enclosed certificate under Reg.74(5) for the period from 1st October 2024 to 31st December, 2024
  • Virinchi L - Shareholders meeting

    6 Jan 2025, 4:43PM Virinchi Limited has submitted the Exchange a copy of Srutinizers report of Postal Ballot.
  • Virinchi L - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    6 Jan 2025, 4:32PM Disclosure of voting results and scrutinizer's report
  • Virinchi L - Trading Window-XBRL

    30 Dec 2024, 3:41PM VIRINCHI LIMITED has informed the Exchange about Closure of Trading Window
  • Virinchi L - Trading Window

    30 Dec 2024, 3:40PM Virinchi Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Virinchi signs contract with overseas

    18 Apr 2018 , 12:56PM Virinchi rises by 13% at Rs130, after company signs a multi-product 5-year contract with Advance America in USA
  • Virinchi enters into strategic collaboration with MedGenome

    22 Nov 2017 , 11:21AM Virinchi announces that Virinchi Hospitals, its 100% subsidiary enters into a strategic collaboration with MedGenome

Key fundamentals

Evaluate the intrinsic value of Virinchi Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 528.3474 429.9895 361.0196 341.4728 316.3674
Liabilities 528.3474 429.9895 361.0196 341.4728 316.3674
Equity 93.9626 83.639 79.3205 36.9935 32.7207
Gross Profit 27.1781 28.3278 30.041 35.2535 43.5005
Net Profit 11.0809 12.4297 12.3671 8.5925 16.8509
Cash From Operating Activities 45.7934 20.1459 6.1955 -2.1429 7.578
NPM(%) 8.36 9.78 9.8 6.46 12.06
Revenue 132.4767 126.9665 126.1648 132.9529 139.7037
Expenses 105.2986 98.6387 96.1238 97.6994 96.2031
ROE(%) 2.29 2.57 2.56 1.78 3.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Virinchi Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
ROX Hi-Tech Ltd 52.10 -4.93 5.60 53.96 93.02 0.00
Tata Consultancy Services Ltd 3511.05 0.14 26.05 8554.06 12688.47 2.08
Accelya Solutions India Ltd 1276.45 -0.18 19.80 35.27 628.74 5.09
Allied Digital Services Ltd 189.77 -0.92 19.87 130.67 162.64 0.79

Company Info

2006 -Virinchi Technologies Ltd on Sept 13, 2006, appointed Anil Kumar Pinapala as Chief Executive Officer (CEO) of the Company. 2007 -Company has informed that the Company has designated the following E-mail ID for the purpose of redressal of Investor Complaints. E-mail ID - tagore@virinchi.com 2010 -The Company has recommended 5% (50 Paise on the face value of Rs.10/- each) dividend for the year 2009-10. 2011 -The Company has recommended 5% dividend (Rs. 0.50 paisa per Equity Share of Rs. 10/- each) for the year 2010-11. 2012 -The Company has recommended 5% dividend (Rs. 0.50 paise per Equity Share of Rs.10/- each) for the year 2011-12. 2013 -Virinchi Acquires Asclepius Consulting to enhance top management band width -Virinchi Technologies acquires majority stake in Asclepius Consulting 2016 -The Name of the Company Changed from "Virinchi Technologies Ltd to Virinchi Ltd". -The Company has launched Virinchi Health Care Mobile App. -Subsidiary of Virinchi Ltd. has opened its first super specialty hospital in Hyderabad. 2017 -Virinchi Limited has been awarded "The Best in Revenue among the IT SMEs for the year 2015-16" by State Govt. of Telangana on the eve of State formation Day -Virinchi awarded as 'The Best Indian IT SME for the year 2015-16' by HYSEA. -Virinchi Hospitals received The Times Health Care 2017 Award as the "Emerging hospital of the year in multi-Specialty Hospital category". -Virinchi signs multi-year contract for its product. -"Virinchi Signs-up with one more leading Alternative Financing Lender in USA for providing its product 'Qfund on Cloud' on an annuity model". 2018 -Virinchi starts work on phase 2 of Banjara Hills facility. -Virinchi signs multi-product contract with Advance America. 2019 -Product Launch-Vcard - India'S First UPI Based Credit Card. 2022 -The Company has issued Bonus Shares in the Ratio of 1:1.

2006 -Virinchi Technologies Ltd on Sept 13, 2006, appointed Anil Kumar Pinapala as Chief Executive Officer (CEO) of the Company. 2007 -Company has informed that the Company has designated the following E-mail ID for the purpose of redressal of Investor Complaints. E-mail ID - tagore@virinchi.com 2010 -The Company has recommended 5% (50 Paise on the face value of Rs.10/- each) dividend for the year 2009-10. 2011 -The Company has recommended 5% dividend (Rs. 0.50 paisa per Equity Share of Rs. 10/- each) for the year 2010-11. 2012 -The Company has recommended 5% dividend (Rs. 0.50 paise per Equity Share of Rs.10/- each) for the year 2011-12. 2013 -Virinchi Acquires Asclepius Consulting to enhance top management band width -Virinchi Technologies acquires majority stake in Asclepius Consulting 2016 -The Name of the Company Changed from "Virinchi Technologies Ltd to Virinchi Ltd". -The Company has launched Virinchi Health Care Mobile App. -Subsidiary of Virinchi Ltd. has opened its first super specialty hospital in Hyderabad. 2017 -Virinchi Limited has been awarded "The Best in Revenue among the IT SMEs for the year 2015-16" by State Govt. of Telangana on the eve of State formation Day -Virinchi awarded as 'The Best Indian IT SME for the year 2015-16' by HYSEA. -Virinchi Hospitals received The Times Health Care 2017 Award as the "Emerging hospital of the year in multi-Specialty Hospital category". -Virinchi signs multi-year contract for its product. -"Virinchi Signs-up with one more leading Alternative Financing Lender in USA for providing its product 'Qfund on Cloud' on an annuity model". 2018 -Virinchi starts work on phase 2 of Banjara Hills facility. -Virinchi signs multi-product contract with Advance America. 2019 -Product Launch-Vcard - India'S First UPI Based Credit Card. 2022 -The Company has issued Bonus Shares in the Ratio of 1:1.

Read More

Parent Organisation

Virinchi Ltd.

Founded

13/03/1990

Managing Director

NSE Symbol

VIRINCHIEQ

FAQ

The current price of Virinchi Ltd is ₹ 23.65.

The 52-week high for Virinchi Ltd is ₹ 24.41 and the 52-week low is ₹ 23.59.

The market capitalization of Virinchi Ltd is currently ₹ 242.76. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Virinchi Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Virinchi Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Virinchi Ltd shares.

The CEO of Virinchi Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT